A new study shows how dysfunctional packaging of the neurotransmitter dopamine triggers toxic processes in neurons—and how ...

A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is ...

Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid improvement in symptoms for patients suffering for decades from the neurological ...

Brought into the limelight by actor Michael J. Fox, Parkinson's disease affects the body's ability to control movement. The most prominent signs of Parkinson's disease result from damage to brain ...

The standard medication levodopa does not always work against tremors in Parkinson's disease, especially in stressful situations. Propranolol, however, does work during stress, providing insight into ...

A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how scientists think about Parkinson's disease treatments. Published in Nature ...

Researchers have identified a neurochemical signature that sets Parkinson's disease apart from essential tremor—two of the most common movement disorders, but each linked to distinct changes in the ...

Millions of people worldwide are affected by Parkinson’s disease, which can cause movement disorders like tremor. But a different disorder known as essential tremor may impact even more people.

A new study shows how dysfunctional packaging of the neurotransmitter dopamine triggers toxic processes in neurons – and how this can be repaired with simple delivery of energy (ATP).